Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management

22 Aug 2019

Abstract excerpt

CONTEXT: It is increasingly evident that non-protein-coding regions of the genome can give rise to transcripts that form functional layers of the cancer genome. One of most abundant classes in these regions is long noncoding RNAs (lncRNAs). They have gained increasing attention in prostate cancer (PCa) and paved the way for a greater understanding of these cryptic regulators in cancer. OBJECTIVE: To review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31445843
DOI: 10.1016/j.eururo.2019.07.040

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease managementPMID 31445843Read ↗

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate CancerSemantic proximity Read ↗

Prostate cancer-associated lncRNAs.Semantic proximity Read ↗

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?Semantic proximity Read ↗

Noncoding RNAs in prostate cancer: the long and the short of it.Semantic proximity Read ↗

Long non-coding RNAs and prostate cancer.Semantic proximity Read ↗

Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancerSemantic proximity Read ↗

Characterization and validation of long noncoding RNAs as new candidates in prostate cancerSemantic proximity Read ↗

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancerSemantic proximity Read ↗

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for interventionSemantic proximity Read ↗

Non-Coding RNA Biomarkers in Prostate Cancer: Evidence Mapping and in Silico CharacterizationSemantic proximity Read ↗

Identification and Characterization of PLUTO-201, a Novel Long Non-Coding RNA Associated with Poor Outcomes in Prostate CancerSemantic proximity Read ↗

Epigenetics-Based Diagnostic and Therapeutic Strategies: Shifting the Paradigm in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.